Speaking of expansion. From this: ''We apply a human B-lymphoblastoid cell-line 721.221 (hereinafter, 221)-based artificial feeder cell system with membrane-bound interleukin 21 (mIL 21) to propagate NK and CAR-NK cells. The expansion capability, purity, and cytotoxicity of NK cells expanded with 221-mIL-21 feeder cells are superior to that of conventional K562-mIL-21 feeder cells. RNA sequencing (RNA-seq) data show that 221-mIL-21 feeder cell-expanded NK cells display a less differentiated, non-exhausted, limited fratricidal, memory-like phenotype correlated with enriched metabolic pathways, which explains underlying mechanisms.'' https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(20)30138-8
Also, additional ways that could improve it https://ashpublications.org/blood/article/118/21/4035/68863/Nicotinamide-a-Form-of-Vitamin-B3-Promotes https://aacrjournals.org/cancerres/article/77/20/5664/623001/GSK3-Inhibition-Drives-Maturation-of-NK-Cells-and https://www.cell.com/cell-metabolism/fulltext/S1550-4131(21)00130-3
Also, additional ways that could improve it https://ashpublications.org/blood/article/118/21/4035/68863/Nicotinamide-a-Form-of-Vitamin-B3-Promotes https://aacrjournals.org/cancerres/article/77/20/5664/623001/GSK3-Inhibition-Drives-Maturation-of-NK-Cells-and https://www.cell.com/cell-metabolism/fulltext/S1550-4131(21)00130-3
Recent NKTX News
- Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers • GlobeNewswire Inc. • 04/15/2026 08:01:00 PM
- Nkarta to Participate in Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/06/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 09:29:06 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/25/2026 09:23:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/25/2026 08:07:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:04:17 PM
- Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 03/25/2026 08:01:00 PM
- Nkarta to Participate in March Investor Conferences • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 10:38:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 10:50:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 10:49:10 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/05/2026 09:43:55 PM
- Nkarta to Participate in Evercore Healthcare Conference • GlobeNewswire Inc. • 12/02/2025 12:09:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 09:18:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:13:36 PM
- Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 11/10/2025 09:01:00 PM
- Nkarta to Participate in November Investor Conferences • GlobeNewswire Inc. • 10/30/2025 05:14:55 PM
- Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting • GlobeNewswire Inc. • 10/22/2025 02:07:45 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/17/2025 10:24:03 PM
- Nkarta to Participate in a September Investor Conference • GlobeNewswire Inc. • 09/02/2025 12:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2025 08:17:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2025 08:08:09 PM
- Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 08/12/2025 08:01:00 PM
